Hisataka Kobayashi
#134,860
Most Influential Person Now
Researcher
Hisataka Kobayashi's AcademicInfluence.com Rankings
Hisataka Kobayashicomputer-science Degrees
Computer Science
#6135
World Rank
#6466
Historical Rank
Machine Learning
#1892
World Rank
#1917
Historical Rank
Artificial Intelligence
#2141
World Rank
#2177
Historical Rank
Database
#3248
World Rank
#3384
Historical Rank
Download Badge
Computer Science
Hisataka Kobayashi's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Hisataka Kobayashi Influential?
(Suggest an Edit or Addition)Hisataka Kobayashi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- New strategies for fluorescent probe design in medical diagnostic imaging. (2010) (1752)
- Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. (2008) (1645)
- Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules (2011) (760)
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? (2013) (739)
- Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes (2009) (704)
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? (2016) (580)
- Nano-sized MRI contrast agents with dendrimer cores. (2005) (414)
- Toxicity of Organic Fluorophores Used in Molecular Imaging: Literature Review (2009) (370)
- Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe (2011) (355)
- Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. (2011) (339)
- Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. (2007) (304)
- In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. (2009) (285)
- Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. (2005) (255)
- Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. (2003) (254)
- Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo (2015) (243)
- Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. (2006) (242)
- Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. (2002) (219)
- Fluorescence-Guided Surgery (2017) (211)
- Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. (2013) (203)
- Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. (2007) (176)
- Near-Infrared Photoimmunotherapy of Cancer (2019) (171)
- Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. (2011) (163)
- H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. (2009) (160)
- Macromolecular MRI contrast agents for imaging tumor angiogenesis. (2006) (153)
- Biologically optimized nanosized molecules and particles: more than just size. (2011) (153)
- Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity (2017) (152)
- Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy (2016) (149)
- An enzymatically activated fluorescence probe for targeted tumor imaging. (2007) (149)
- Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. (2004) (142)
- Dendrimer-based nanosized MRI contrast agents. (2004) (141)
- Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. (2012) (140)
- 3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties (2001) (140)
- Clinical implications of near-infrared fluorescence imaging in cancer. (2009) (138)
- Dendrimer-based macromolecular MRI contrast agents: characteristics and application. (2003) (135)
- Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores (2001) (134)
- A dendrimer‐based nanosized contrast agent dual‐labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice (2007) (133)
- Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. (2006) (133)
- Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. (2002) (130)
- Imaging of the lymphatic system: new horizons. (2006) (128)
- Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy (2018) (127)
- Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. (2011) (120)
- Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity (2007) (119)
- Dendrimer-based contrast agents for molecular imaging. (2008) (116)
- Near-IR Light-Mediated Cleavage of Antibody-Drug Conjugates Using Cyanine Photocages. (2015) (114)
- In vivo Diagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal Antibodies (2007) (112)
- Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. (2007) (110)
- Positive effects of polyethylene glycol conjugation to generation‐4 polyamidoamine dendrimers as macromolecular MR contrast agents (2001) (109)
- Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. (2011) (108)
- Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. (2003) (106)
- In vivo multiple color lymphatic imaging using upconverting nanocrystals (2009) (105)
- Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). (2002) (104)
- In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. (2007) (101)
- Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. (2009) (100)
- Comparison of dendrimer‐based macromolecular contrast agents for dynamic micro‐magnetic resonance lymphangiography (2003) (100)
- A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. (2007) (100)
- Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity (2000) (98)
- Posterior cul-de-sac obliteration associated with endometriosis: MR imaging evaluation. (2005) (97)
- Near infrared fluorescence‐guided real‐time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green (2011) (97)
- Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe (2012) (96)
- Inflammatory breast cancer: Vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model (2003) (96)
- Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. (2010) (96)
- Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. (2009) (95)
- Imaging of tumor angiogenesis: functional or targeted? (2009) (95)
- In Vivo Activation of Duocarmycin–Antibody Conjugates by Near-Infrared Light (2017) (92)
- In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies (2009) (92)
- Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy (2012) (88)
- Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. (2002) (87)
- In vivo real-time, multicolor, quantum dot lymphatic imaging. (2009) (84)
- Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor (2014) (84)
- Micro‐MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: Reference to pharmacokinetic properties of dendrimer‐based MR contrast agents (2001) (83)
- Application of a Macromolecular Contrast Agent for Detection of Alterations of Tumor Vessel Permeability Induced by Radiation (2004) (81)
- Uterine peristalsis shown on cine MR imaging using ultrafast sequence (2003) (77)
- Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core (2001) (77)
- Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer (2014) (76)
- Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green (2015) (75)
- Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience (2015) (74)
- Determination of optimal rhodamine fluorophore for in vivo optical imaging. (2008) (74)
- Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu (2007) (74)
- Improving the Efficacy of Photoimmunotherapy (PIT) using a Cocktail of Antibody Conjugates in a Multiple Antigen Tumor Model (2013) (73)
- Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors (2019) (72)
- Multiplexed imaging in cancer diagnosis: applications and future advances. (2010) (71)
- In vivo molecular imaging using nanomaterials: General in vivo characteristics of nano-sized reagents and applications for cancer diagnosis (Review) (2010) (70)
- Multiplexing with multispectral imaging: from mice to microscopy. (2008) (70)
- Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen (2015) (69)
- Polyamine dendrimer‐based MRI contrast agents for functional kidney imaging to diagnose acute renal failure (2004) (68)
- Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity. (2020) (67)
- Molecular probes for the in vivo imaging of cancer. (2009) (66)
- Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. (2012) (65)
- Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy. (2016) (65)
- Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody (2016) (64)
- Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates (2014) (64)
- Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies? (2015) (64)
- Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies (2016) (64)
- Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model (2014) (63)
- Phototheranostics of CD44-positive cell populations in triple negative breast cancer (2016) (62)
- Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody (2017) (62)
- High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer (2019) (61)
- Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. (2007) (61)
- Detection of inflammation following renal ischemia by magnetic resonance imaging. (2003) (60)
- Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapy. (2015) (59)
- In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. (2006) (59)
- Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application (2003) (59)
- Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. (2009) (59)
- In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores (2012) (59)
- Nanoparticles in sentinel lymph node mapping. (2009) (58)
- Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti–CD44-Based NIR-PIT (2017) (58)
- High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation. (2010) (56)
- Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. (2005) (56)
- Diagnostic Value of Tc‐99m (V) DMSA for Chondrogenic Tumors With Positive Tc‐99m HMDP Uptake on Bone Scintigraphy (1995) (55)
- Near infrared photoimmunotherapy for lung metastases. (2015) (53)
- Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases. (2012) (53)
- Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. (2005) (53)
- Near Infra-Red Photoimmunotherapy with Anti-CEA-IR700 Results in Extensive Tumor Lysis and a Significant Decrease in Tumor Burden in Orthotopic Mouse Models of Pancreatic Cancer (2015) (53)
- Septum-like structures in lipoma and liposarcoma: MR imaging and pathologic correlation (1997) (53)
- Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer (2017) (52)
- A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. (2006) (52)
- The Effect of Photoimmunotherapy Followed by Liposomal Daunorubicin in a Mixed Tumor Model: A Demonstration of the Super-Enhanced Permeability and Retention Effect after Photoimmunotherapy (2013) (51)
- Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. (2007) (50)
- Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry. (2007) (50)
- Activatable optical imaging with a silica-rhodamine based near infrared (SiR700) fluorophore: a comparison with cyanine based dyes. (2011) (50)
- Multicolor in vivo targeted imaging to guide real‐time surgery of HER2‐positive micrometastases in a two‐tumor coincident model of ovarian cancer (2009) (49)
- Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. (2013) (48)
- Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. (2006) (47)
- Role of Fluorophore Charge on the In Vivo Optical Imaging Properties of Near-Infrared Cyanine Dye/Monoclonal Antibody Conjugates. (2016) (46)
- Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel. (2015) (46)
- New approaches to lymphatic imaging. (2009) (46)
- 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent (2001) (45)
- A Near-Infrared, Wavelength-Shiftable, Turn-on Fluorescent Probe for the Detection and Imaging of Cancer Tumor Cells. (2017) (45)
- Near infrared photoimmunotherapy of B‐cell lymphoma (2016) (45)
- Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. (2012) (45)
- Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT) (2019) (45)
- Real-time optical imaging using quantum dot and related nanocrystals. (2010) (45)
- Near infrared photoimmunotherapy with an anti-mesothelin antibody (2016) (44)
- In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. (2009) (43)
- Near Infrared Photoimmunotherapy for Cancer (2019) (43)
- Herceptin-Geldanamycin Immunoconjugates (2004) (43)
- Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. (2005) (42)
- D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green. (2007) (41)
- New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. (2010) (41)
- Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy (2016) (41)
- Pancreatic cavernous hemangioma: CT, MRI, US, and angiography characteristics (2005) (40)
- The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity (2014) (39)
- A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A “Smart” Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases (2007) (39)
- Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers (2018) (39)
- Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. (2004) (39)
- Novel intravascular macromolecular MRI contrast agent with generation‐4 polyamidoamine dendrimer core: Accelerated renal excretion with coinjection of lysine (2001) (38)
- Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources. (2018) (38)
- Reduction of Streptococcus mutans Adherence and Dental Biofilm Formation by Surface Treatment with Phosphorylated Polyethylene Glycol (2007) (38)
- Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models (2020) (38)
- Gadolinium-labeled dendrimers as biometric nanoprobes to detect vascular permeability (2003) (38)
- Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model (2015) (38)
- Dendrimers as high relaxivity MR contrast agents. (2014) (38)
- Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. (2010) (37)
- Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission (2014) (37)
- Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations. (2017) (37)
- Near Infrared Photoimmunotherapy: Photo-Activatable Antibody-Drug Conjugates (ADCs). (2019) (35)
- Activatable Organic Near-Infrared Fluorescent Probes Based on a Bacteriochlorin Platform: Synthesis and Multicolor in Vivo Imaging with a Single Excitation (2014) (35)
- Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates. (2015) (35)
- Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer (2018) (34)
- Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology. (2016) (34)
- Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms (2016) (34)
- Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer (2021) (33)
- Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin‐conjugated fluorophore (2007) (33)
- Self-illuminating in vivo lymphatic imaging using a bioluminescence resonance energy transfer quantum dot nano-particle. (2011) (33)
- Minibody-indocyanine green based activatable optical imaging probes: the role of short polyethylene glycol linkers. (2014) (32)
- Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody (2019) (32)
- Quantum dot nanoparticle for optimization of breast cancer diagnostics and therapy in a clinical setting. (2016) (32)
- Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody (2018) (31)
- Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors. (2003) (31)
- Fluorescence lifetime imaging of activatable target specific molecular probes. (2010) (31)
- Preparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging. (2015) (30)
- Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase. (2003) (30)
- Production of Multiple Growth Factors by a Newly Established Human Thyroid Carcinoma Cell Line (1992) (30)
- Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates. (2016) (30)
- Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models. (2015) (29)
- Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin (2020) (29)
- Near-infrared photoimmunotherapy: a comparison of light dosing schedules (2017) (29)
- Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine. (2015) (29)
- Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI (2017) (29)
- Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma (2019) (29)
- Micro-MRI methods to detect renal cysts in mice. (2004) (28)
- The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near Infrared Photoimmunotherapy (NIR-PIT). (2019) (28)
- Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging (2016) (28)
- Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer. (2009) (27)
- Imaging Acute Renal Failure with Polyamine Dendrimer-Based MRI Contrast Agents (2006) (26)
- Molecular imaging of tumor invasion and metastases: the role of MRI (2010) (26)
- Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer (2016) (26)
- Acute Cytotoxic Effects of Photoimmunotherapy Assessed by 18F-FDG PET (2013) (25)
- Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). (2016) (25)
- Multi-targeted multi-color in vivo optical imaging in a model of disseminated peritoneal ovarian cancer. (2009) (25)
- Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy (2021) (25)
- Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. (2017) (25)
- Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography (2008) (25)
- Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model (2015) (24)
- Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green (2016) (24)
- Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. (2017) (24)
- Avoiding thermal injury during near-infrared photoimmunotherapy (NIR-PIT): the importance of NIR light power density (2017) (24)
- Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells (2015) (24)
- Comparison of the Chase Effects of Avidin, Streptavidin, Neutravidin, and Avidin‐Ferritin on a Radiolabeled Biotinylated Anti‐tumor Monoclonal Antibody (1995) (24)
- Rational Chemical Design of the Next Generation of Molecular Imaging Probes Based on Physics and Biology: Mixing Modalities, Colors and Signals (2011) (24)
- Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification. (2003) (23)
- Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer (2016) (23)
- Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity (2021) (21)
- Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT (2019) (21)
- Multi-Wavelength Fluorescence in Image-Guided Surgery, Clinical Feasibility and Future Perspectives (2020) (21)
- Solitary muscular sarcoidosis: CT, MRI, and scintigraphic characteristics (1994) (21)
- Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors (2020) (20)
- Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination (2018) (20)
- Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging. (2010) (20)
- Real‐time monitoring of microdistribution of antibody‐photon absorber conjugates during photoimmunotherapy in vivo (2017) (20)
- Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer. (2018) (20)
- Real-time monitoring of hemodynamic changes in tumor vessels during photoimmunotherapy using optical coherence tomography (2014) (20)
- Norcyanine-Carbamates Are Versatile Near-Infrared Fluorogenic Probes. (2021) (20)
- In Vivo Longitudinal Imaging of Experimental Human Papillomavirus Infection in Mice with a Multicolor Fluorescence Mini-Endoscopy System (2011) (19)
- MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals. (2012) (19)
- Near infrared photoimmunotherapy for cancers: A translational perspective (2021) (19)
- Cerenkov Radiation–Induced Photoimmunotherapy with 18F-FDG (2017) (19)
- Design strategy for germanium-rhodamine based pH-activatable near-infrared fluorescence probes suitable for biological applications (2019) (19)
- MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy (2016) (19)
- Semiquantitative assessment of the microdistribution of fluorescence‐labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer (2010) (19)
- Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis. (2010) (19)
- Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin–Antibody Conjugate (2017) (19)
- 3D mesoscopic fluorescence tomography for imaging micro‐distribution of antibody‐photon absorber conjugates during near infrared photoimmunotherapy in vivo (2018) (18)
- Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging (2013) (18)
- Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models (2020) (18)
- Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy (2020) (18)
- Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model. (2015) (18)
- Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location (2007) (18)
- Polysplenia associated with semiannular pancreas (2001) (18)
- Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy (2017) (17)
- Detecting tumour-positive resection margins after oral cancer surgery by spraying a fluorescent tracer activated by gamma-glutamyltranspeptidase. (2018) (17)
- Enhanced nanodrug delivery in tumors after near-infrared photoimmunotherapy (2019) (17)
- Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer (2016) (17)
- A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-βGal for detecting cancer: Advantages of anchoring to cellular proteins after activation (2017) (17)
- In vivo real-time lymphatic draining using quantum-dot optical imaging in mice. (2013) (17)
- Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications. (2002) (17)
- Implantable wireless powered light emitting diode (LED) for near-infrared photoimmunotherapy: device development and experimental assessment in vitro and in vivo (2018) (16)
- Synthesis and biodistribution study of a new 211At-calix[4]arene complex (2000) (16)
- Analysis of Biodistribution of Intracranially Infused Radiolabeled Interleukin-13 Receptor–Targeted Immunotoxin IL-13PE by SPECT/CT in an Orthotopic Mouse Model of Human Glioma (2014) (15)
- Near infrared photoimmunotherapy of cancer; possible clinical applications (2021) (15)
- Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagents. (2002) (15)
- Construction of Immunoradiometric Assay for Circulating c‐erbB‐2 Protooncogene Product in Advanced Breast Cancer Patients (1993) (15)
- A Portable Fluorescence Camera for Testing Surgical Specimens in the Operating Room: Description and Early Evaluation (2011) (15)
- Modifications in synthesis strategy improve the yield and efficacy of geldanamycin-herceptin immunoconjugates. (2002) (14)
- Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials (2021) (14)
- Optimizing quantitative in vivo fluorescence imaging with near-infrared quantum dots. (2011) (14)
- Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose (2003) (13)
- The use of fluorescent proteins for developing cancer-specific target imaging probes. (2012) (13)
- Polychromatic in vivo imaging of multiple targets using visible and near infrared light. (2013) (13)
- MR lymphangiography using dendrimer‐based contrast agents: A comparison at 1.5T and 3.0T (2007) (13)
- Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging. (2007) (13)
- Fluorescence imaging of tumors with "smart" pH-activatable targeted probes. (2009) (12)
- Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. (2021) (12)
- Near‐infrared photoimmunotherapy through bone (2019) (12)
- Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model (2021) (12)
- Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy. (2014) (12)
- Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models (2021) (12)
- Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe (2016) (10)
- Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy. (2021) (10)
- Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity (2019) (10)
- Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression (2021) (10)
- Alterations of filopodia by near infrared photoimmunotherapy: evaluation with 3D low-coherent quantitative phase microscopy. (2016) (10)
- Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates (2016) (9)
- Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model. (2014) (9)
- Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green. (2021) (9)
- Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab-IR700 for Near-Infrared Photoimmunotherapy. (2020) (9)
- CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model (2022) (8)
- Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine (2020) (8)
- Lymphatic drainage imaging of the breast cancer in mice using the micro-magnetic resonance mammo-lymphangiography using a nano-size contrast agent (2004) (8)
- Vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model (2003) (8)
- Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green (2021) (8)
- MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates (2014) (8)
- for Radioiodide Concentrator Gene Therapy (2000) (8)
- Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1). (2017) (7)
- Spectral near-infrared fluorescence imaging of curved surfaces using projection reconstruction algorithms. (2007) (7)
- Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factor (1993) (7)
- Effect of Circulating Antigen on Immunoscintigraphy of Ovarian Cancer Patients Using Anti‐CA125 Monoclonal Antibody (1996) (6)
- Surgical tissue handling methods to optimize ex vivo fluorescence with the activatable optical probe γ-glutamyl hydroxymethyl rhodamine green. (2016) (6)
- Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy (2022) (6)
- Targeted, Activatable, IN VIVO Fluorescence Imaging of Prostate-specific Membrane Antigen (PSMA)-positive Tumors Using the Quenched Humanized J591 Antibody-ICG Conjugate (2011) (6)
- Spectral FluorescenceMolecular Imaging of LungMetastases Targeting HER 2 / neu (2007) (6)
- A near-infrared light-mediated cleavable linker strategy using the heptamethine cyanine chromophore. (2020) (6)
- Activatable optical imaging probes with various fluorophore-quencher combinations (2009) (5)
- Dynamic micro-MRI of liver micrometastasis with a novel liver macromolecular MR contrast agent DAB-Am64-(1B4M-Gd)64. (2002) (5)
- Cyanine Phototruncation Enables Spatiotemporal Cell Labeling. (2022) (5)
- Advances in Brief Dynamic Micro-Magnetic Resonance Imaging of Liver Micrometastasis in Mice with a Novel Liver Macromolecular Magnetic Resonance Contrast Agent DAB-Am 64-( 1 B 4 MGd ) 64 (2001) (5)
- Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites (2014) (5)
- Quantitative and specific molecular imaging of cancer with labeled engineered monoclonal antibody fragments. (2011) (4)
- Microdistribution of fluorescently-labeled monoclonal antibody in a peritoneal dissemination model of ovarian cancer (2010) (4)
- Monoclonal antibody-fluorescent probe conjugates for in vivo target-specific cancer imaging: toward clinical translation. (2013) (4)
- Illuminating the cancer-targeting potential of near-infrared photoimmunotherapy (2016) (4)
- Near-Infrared Photoimmunotherapy for Cancers of the Gastrointestinal Tract (2020) (4)
- Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1) (2017) (4)
- Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid (1995) (4)
- Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers (2022) (4)
- Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody (2005) (4)
- Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice (2022) (4)
- Effect of Short PEG on Near-Infrared BODIPY-Based Activatable Optical Probes (2020) (4)
- Glucose 1-phosphate increases active transport of calcium in intestine. (2007) (4)
- of Inflammation: Concanavalin A-Mediated Lymphocyte Activation (2002) (4)
- Wound healing after excision of subcutaneous tumors treated with near‐infrared photoimmunotherapy (2020) (3)
- Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice (2020) (3)
- Antimicrobial strategy for targeted elimination of different microbes, including bacterial, fungal and viral pathogens (2022) (3)
- Technetium-99m (V)-dimercaptosuccinic acid: Normal accumulation in the breasts (1997) (3)
- Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy (2022) (3)
- Near‐infrared‐induced drug release from antibody–drug double conjugates exerts a cytotoxic photo‐bystander effect (2022) (3)
- CMR 2007: 2.06: A multi-modal and multi-color dendrimer-based nano-sized contrast agent for near-infrared optical and radionuclide lymphatic imaging (2007) (3)
- PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model (2022) (3)
- Changes in the lymphatic architecture in the labial gingiva at the mandibular incisor after carbon dioxide laser irradiation (2001) (2)
- Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration (2022) (2)
- HPV based photodynamic therapy: a new approach for anti-cancer therapy (VAC12P.1019) (2014) (2)
- Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT) (2017) (2)
- Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts (2022) (2)
- Quantitative analysis of vascular changes during photoimmunotherapy using speckle variance optical coherence tomography (SV-OCT). (2021) (2)
- Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer (2022) (2)
- Expanding the application of cancer near-infrared photoimmunotherapy (2021) (2)
- Whole-body multicolor spectrally resolved fluorescence imaging for development of target-specific optical contrast agents using genetically engineered probes (2007) (2)
- Endoscopic molecular imaging of cancer. (2013) (2)
- Abstract 3831: Development of near-infrared photoimmunotherapy targeting GD2-positive neuroblastoma (2018) (2)
- Lymphangiogenesis and Imaging of the Lymphatics in Cancer (2009) (2)
- Paraneoplastic syndromes associated with ovarian neoplasms (2000) (2)
- CMR 2005: 5.04: Dendrimer-based nano-sized contrast agents for functional renal MRI: new insights into pathogenesis of acute renal diseases (2006) (1)
- Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin (2022) (1)
- A flexible target-specific anti-infection therapeutic platform that can be applied to different microbial species (2020) (1)
- The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity (2014) (1)
- Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a {open_quotes}chase{close_quotes} without decreased accumulation in the target tumor (1994) (1)
- Abstract LB-508: A GSA-NMP1 conjugate: An NIR-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases (2012) (1)
- Evaluating near‐infrared photoimmunotherapy for targeting fibroblast activation protein‐α expressing cells in vitro and in vivo (2022) (1)
- Reduced bone marrow uptake of indium-111 labelled monoclonal antibody after radiotherapy (1994) (1)
- Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response (2022) (1)
- Epitope Blocking: Positive and Negative Effects on the Biodistribution of 125I‐Labeled Anti‐Tac Disulfide‐stabilized Fv Fragment of Two Antibodies against Different Epitopes of the Circulating Antigen (1998) (1)
- Near infrared photoimmunotherapy: a new type of immune theranostic technology for cancer (2020) (1)
- Abstract 5400: Photoimmunotherapy (PIT) combined with a nanosized cancer agent successfully treated heterogenous antigen-expressing tumors based on super-enhanced permeability and retention (SUPR) effect (2014) (1)
- Current and new fluorescent probes for fluorescence-guided surgery (2020) (1)
- Comparison of the Effectiveness of IgG Antibody versus F(ab')2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy. (2022) (1)
- Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy (2022) (1)
- Application of Dendrimer Molecules in Bioimaging and Cancer Treatment (2009) (1)
- Multi-excitation near infrared (NIR) spectral fluorescence imaging using organic fluorophores (2008) (1)
- Response to Comment on “Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe” (2012) (1)
- Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment (2022) (1)
- In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores (2012) (1)
- Functional kidney imaging in mice using dendrimer based renal contrast agents (2002) (1)
- Recipe for a new imaging biomarker: carefully combine target, reagent, and technology. (2012) (1)
- Immunoscintigraphy of colorectal cancer using111In-labeled monoclonal antibody to mucin (1995) (1)
- Eliminating fibroblast activation protein-α expressing cells by photoimmunotheranostics (2021) (1)
- Investigation of dynamic morphological changes of cancer cells during photoimmuno therapy (PIT) by low-coherence quantitative phase microscopy (2014) (1)
- Pitfalls on sample preparation for ex vivo imaging of resected cancer tissue using enzyme-activatable fluorescent probes (2018) (1)
- Future applications of and prospects for near-IR photoimmunotherapy: benefits and differences compared with photodynamic and photothermal therapy. (2021) (1)
- Early phase dynamics of traceable mCherry fluorescent protein‐carrying HIV‐1 infection in human peripheral blood mononuclear cells‐transplanted NOD/SCID/Jak3‐/‐ mice (2017) (1)
- Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers (2022) (1)
- Properties and Applications of Nonionic Surfactants Derived from Saccharides to Shampoo. (1993) (1)
- Comparison of Macromolecular Contrast Agents for Dynamic Micromagnetic Resonance Lymphangiography (2005) (0)
- Abstract 4118: Near infrared photoimmunotherapy for lung metastases (2015) (0)
- Improving cancer cell imaging (2009) (0)
- Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. (2022) (0)
- Abstract 4830: Target-molecular specific near infrared cancer photoimmunotherapy: Detection, treatment, and monitoring of tumors with a theranostic fluorescent probe (2012) (0)
- Photo-immunotherapy: A newly developed, target cell-specific cancer therapy (2014) (0)
- Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence Imaging. (2022) (0)
- CMR 2005: 3.04: Sentinel node imaging of breast cancer in mice using a dual‐labeled nano‐sized MRI–near‐infrared optical hybrid contrast agent (2006) (0)
- Abstract 696: Phototheranostics of epithelioid sarcoma by targeting CD44 or EGFR (2021) (0)
- Tumor‐targeted fluorescence labeling systems for cancer diagnosis and treatment (2022) (0)
- Endoscopic Optical Biopsy of Experimental Colitis Associated Cancer Using a Gamma-Glutamyltransferase Activatable Fluorescence Imaging Probe (2011) (0)
- Abstract 401: A novel photoimmunotherapy targeting cancer-associated fibroblasts (CAFs) overcomes therapeutic resistance in human esophageal cancer (2015) (0)
- Abstract A09: Photoimmunotherapy (PIT) for treatment of bladder cancer (2020) (0)
- Abstract 1470: Cancer treatment by near infrared photoimmunotherapy targeting intratumoral regulatory T cells (2016) (0)
- Yasuteru Urano Activated Fluorescent Probe −-Glutamyltranspeptidase γ Rapid Cancer Detection by Topically Spraying a (2011) (0)
- Abstract 5110: Locally administered Interleukin-15 combined with cancer cell-targeted near-infrared photoimmunotherapy in a syngeneic mouse cancer model (2023) (0)
- Abstract 2484: IR700-conjugated anti-CD44 monoclonal antibody for phototherapy theranostics of triple-negative breast cancer (2015) (0)
- Abstract 2615: Novel combination therapy of adenoviral gene transfer of HER2-extracellular domain and trastuzumab-based photoimmunotherapy for HER2 negative cancer cells (2014) (0)
- Epidermal growth factor receptor (EGFR) targeted photoimmunotherapy (PIT) for the treatment of EGFR expressing bladder cancer. (2017) (0)
- P3.02c-071 Spatially Selective Depletion of Regulatory T Cells with near Infrared Photoimmunotherapy for Syngeneic Lewis Lung Carcinoma: Topic: IT Biomarkers (2017) (0)
- Tumor-targeted optical imaging in the management of peritoneal carcinomatosis. (2007) (0)
- Development of a novel bio-imaging approach for assessing biodistribution of IL-13PE immunotoxin in targeting intracranial interleukin-13 receptor positive glioblastoma tumors in mouse model (2011) (0)
- Development of new photo-activated local cancer immunotherapy: targeting tumor infiltrating regulatory T cells. (2017) (0)
- Abstract 4512: Super-enhanced permeability and retention (SUPR) effect induced by photo-immunotherapy (PIT) can accommodate massive nano-sized reagents deep into tumors. (2013) (0)
- Abstract 3311: Molecular targeted photoimmunotherapy as a treatment for bladder cancer (2015) (0)
- Near infrared photo-immunotherapy: A newly developed, target cell-specific cancer theranostic technology (2015) (0)
- Abstract 3444: Intratumor regulatory T cells prevent IFN-gamma-dependent tumor vessel regression and can be selectively targeted by anti-CD25 near-infrared photoimmunotherapy (2020) (0)
- IMPROVEMENT OF MACROMOLECULAR CLEARANCE VIA LYMPH FLOW IN HAMSTER GINGIVA BY TOPICAL WARMING PLUS MASSAGE AND LOW-POWER CARBON DIOXIDE LASER IRRADIATION (2001) (0)
- Target cell specific antibody-based photosensitizers for photodynamic therapy (2011) (0)
- Evaluation of intracranial distribution of interleukin-13 receptor directed immunotoxin after convection enhanced delivery by SPECT/CT in a human brain tumor mouse model (2014) (0)
- Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy (2012) (0)
- Abstract 5066: Dual-targeting photoimmunotherapy (NIR-PIT) for esophageal cancer cells and cancer-associated fibroblasts (CAFs) (2018) (0)
- In vivo real-time monitoring of cancer cell viability using a molecularly targeted pH-activatable fluorescent imaging probe (2008) (0)
- Abstract 4332: Ultra-low background optical sentinel lymph node imaging using two unique nano-particles (2010) (0)
- Spatially selective depleting tumor-associated negative regulatory T-(Treg) cells with near infrared photoimmunotherapy (NIR-PIT): A new cancer immunotherapy (Conference Presentation) (2017) (0)
- Cyanine Phototruncation Enables Cell Labeling with Spatiotemporal Control (2022) (0)
- ’ s response to reviews Title : Molecular Targeted Photoimmunotherapy for HER 2-positive Human Gastric Cancer in Combination with Chemotherapy Results in Improved Treatment Outcomes Through Different Cytotoxic Mechanisms (2016) (0)
- Seeing life in a new lightNuanceTM and MaestroTM Imaging Systems (2008) (0)
- Real-time monitoring the distribution of antibody-photo-absorber conjugates during photoimmunotherapy in vivo(Conference Presentation) (2017) (0)
- The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring. (2023) (0)
- Fluorescence in vivo imaging of live tumor cells with pH-activatable targeted probes via receptor-mediated endocytosis (2009) (0)
- List of contributors (2020) (0)
- Abstract 3298: Neotargeting HER2 negative cancer cells with Trastuzumab-based photoimmunotherapy by viral transduction of HER2-extracellular domain. (2013) (0)
- Lymphatic draining patterns following submucosal rectal injections of methylene blue dye. (2014) (0)
- Abstract 2019: Photoimmunotherapy with an anti-EGFR antibody conjugated to an IRDye700 results in extensive and rapid cell death in vitro and in vivo in human pancreatic cancer cell lines (2015) (0)
- Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms (2016) (0)
- Antibody-ir700 conjugates for photodynamic therapy (2012) (0)
- Development of an Imaging Approach for Inflammatory and Neoplastic Ocular Lesions by Establishing Specific Identification of T-cells In Vitro with Indocyanine Green Fluorescence (2014) (0)
- MR Lymphangiography Using Nano-Sized Paramagnetic Contrast Agents with Dendrimer Cores (2008) (0)
- CMR2009: 2.01: Designing cancer cell‐specific fluorescence contrast agents: a flexible approach (2009) (0)
- Eliciting host immunity selectively against cancer cells treated with silica-phthalocyanine-based near infrared photoimmunotherapy (2017) (0)
- STUDIES ON RENAL HYPERTENSION: REPORT 3. EXPERIMENTAL STUDIES ON PERIPHERAL RENAL REVASCULARIZATION@@@第3報 Peripheral renal revascularization についての実験的研究 (1964) (0)
- Part 1 ( Para ) magnetic Nanoparticles : Applications in Magnetic Resonance Imaging (2017) (0)
- Molecular Imaging Probes: Activatable and Sensing Probes (2014) (0)
- Near infrared photoimmunotherapy for cancer; New targets on cancer and immune-suppressive cells (2021) (0)
- In Vivo Pressure and Temperature Monitoring during Near Infrared Photo-Immunotherapy Using a Fiber Optic Sensor (2015) (0)
- 18F-FDG PET can evaluate immediate cytotoxic effects induced by the photoimmunotherapy before changes in tumor size (2012) (0)
- Optical imaging of HPV infection in a murine model. (2013) (0)
- Epidermal Growth Factor Receptor ( EGFR ) Targeted Photoimmunotherapy ( PIT ) for the Treatment of EGFR expressing Bladder Cancer Running Title – Photoimmunotherapy for Treatment of Bladder Cancer (2017) (0)
- Raltegravir blocks the infectivity of red‐fluorescent‐protein (mCherry)‐labeled HIV‐1JR‐FL in the setting of post‐exposure prophylaxis in NOD/SCID/Jak3−/− mice transplanted with human PBMCs (2018) (0)
- Theranostic Near-Infrared Photoimmunotherapy (2019) (0)
- Sprayable enzyme-activatable fluorescent probes: kinetic mapping using dynamic fluorescence imaging can help detecting tiny cancer foci (Conference Presentation) (2017) (0)
- Abstract 3618: Target-specific photo-activatable immunotherapy (PIT) for cancer based on a monoclonal antibody-photosensitizer conjugate (2011) (0)
- Using Monosachharidphosphaten to improve intestinal function (2004) (0)
- Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases. (2023) (0)
- Abstract 3360: Phototheranostics of cancer associated fibroblasts by targeting fibroblast activation protein-α (2020) (0)
- Mechanism of eliciting host immunity against cancer cells treated with silica-phthalocyanine-based near infrared photoimmunotherapy (Conference Presentation) (2016) (0)
- [In-vivo cancer fluorescence imaging with novel precisely-designed fluorescence probes]. (2007) (0)
- [Molecular imaging; current status and future prospects in USA]. (2007) (0)
- Multimodality molecular imaging with activatable fluorescence and radioscintigraphy for specific and quantitative targeted cancer detection (2010) (0)
- TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 EXPRESSING BLADDER CANCER USING COMBINATION PHOTOIMMUNOTHERAPY (PIT): PNFLBA‐12 (2017) (0)
- Near infrared photoimmunotherapy rapidly elicits specific host immunity against cancer cells (Conference Presentation) (2017) (0)
- New technologies of cancer cell-specific molecular imaging and near infrared photoimmunotherapy (2014) (0)
- DENDRIMER-ENHANCED MRI AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER OF SEPSIS IN AGED MICE: 466 (2004) (0)
- 581 - Near Infrared Photoimmunotherapy Using Diffuser for Targeting Peritoneal Gastric Cancer Dissemination (2018) (0)
- Abstract 3206: Host immunity following near infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established highly antigenic tumors (2019) (0)
- Concepts in Diagnostic Probe Design (2017) (0)
- The Endoscopy‐Guided Plan of Radiotherapy for Detecting Esophageal Cancer Using Lugol Staining (1990) (0)
- Abstract #LB-290: Multi-color in vivo targeted imaging to guide real-time surgery of HER2-positive micro-metastases in a two-tumor coincident model of ovarian cancer (2009) (0)
- Activatable Fluorescence Probes for the Cancer-Cell Specific Molecular Imaging of Cancer (2008) (0)
- NIR-PIT: Will it become a standard cancer treatment? (2022) (0)
- Near infrared photoimmunotherapy for cancer: enhanced anti-tumor immunity when combined with immuno-activation therapies (Conference Presentation) (2019) (0)
- Functional and cellular imaging of acute renal failure in the mouse or rat model using gadolinium- and iron-based macromolecular MRI contrast agents (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hisataka Kobayashi?
Hisataka Kobayashi is affiliated with the following schools:
